Midostaurin potentiates rituximab antitumor activity in Burkitts lymphoma by inducing apoptosis

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

22:37 EST 2 Jan 2019 | Nature Publishing

More From BioPortfolio on "Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis"